BR112023001716A2 - Composições farmacêuticas compreendendo api revestido - Google Patents

Composições farmacêuticas compreendendo api revestido

Info

Publication number
BR112023001716A2
BR112023001716A2 BR112023001716A BR112023001716A BR112023001716A2 BR 112023001716 A2 BR112023001716 A2 BR 112023001716A2 BR 112023001716 A BR112023001716 A BR 112023001716A BR 112023001716 A BR112023001716 A BR 112023001716A BR 112023001716 A2 BR112023001716 A2 BR 112023001716A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
coated api
api
coated
coating
Prior art date
Application number
BR112023001716A
Other languages
English (en)
Inventor
Mclaughlin Rosaleen
Andrew Martyn Howes Simon
Wheadon Craig
Whitehouse Jonathon
Parker Adam
John Hutchinson Michael
Original Assignee
Catalent Uk Swindon Zydis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Uk Swindon Zydis Ltd filed Critical Catalent Uk Swindon Zydis Ltd
Publication of BR112023001716A2 publication Critical patent/BR112023001716A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIÇÕES FARMACÊUTICAS COMPREENDENDO API REVESTIDO. A presente invenção refere-se a composições farmacêuticas e métodos para preparar composições farmacêuticas compreendendo API revestido. O excesso de material de revestimento que não está ligado ao API revestido pode ser removido por um processo de peneiramento. As relações de revestimento e dosagem também podem ser otimizadas para minimizar a quantidade de excesso de material de revestimento não ligado. Além disso, as composições podem ser formuladas para preservar o revestimento funcional do API revestido e para minimizar a aeração do API quando misturado em suspensão.
BR112023001716A 2020-07-31 2021-07-30 Composições farmacêuticas compreendendo api revestido BR112023001716A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063059684P 2020-07-31 2020-07-31
PCT/IB2021/056976 WO2022024066A1 (en) 2020-07-31 2021-07-30 Pharmaceutical compositions comprising coated api

Publications (1)

Publication Number Publication Date
BR112023001716A2 true BR112023001716A2 (pt) 2023-04-04

Family

ID=77265127

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023001716A BR112023001716A2 (pt) 2020-07-31 2021-07-30 Composições farmacêuticas compreendendo api revestido

Country Status (12)

Country Link
US (1) US20220031610A1 (pt)
EP (1) EP4188324A1 (pt)
JP (1) JP2023535829A (pt)
CN (1) CN115968281A (pt)
AR (1) AR123109A1 (pt)
AU (1) AU2021317182A1 (pt)
BR (1) BR112023001716A2 (pt)
CA (1) CA3189404A1 (pt)
IL (1) IL300129A (pt)
MX (1) MX2023001004A (pt)
TW (1) TW202220638A (pt)
WO (1) WO2022024066A1 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976577A (en) 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
CA2664097A1 (en) * 2006-09-20 2008-03-27 Monosol Rx, Llc Edible water-soluble film containing a foam reducing flavoring agent
JP5547096B2 (ja) * 2008-02-28 2014-07-09 アール．ピー． シェーラー テクノロジーズ エルエルシー 多型を最小化する方法
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
WO2013183062A2 (en) * 2012-06-05 2013-12-12 Rubicon Research Private Limited Palatable formulations of ibuprofen
US9107851B2 (en) * 2012-10-15 2015-08-18 New Jersey Institute Of Technology Solventless mixing process for coating pharmaceutical ingredients
GB2597577B (en) * 2019-02-22 2023-09-20 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
AU2020225818A1 (en) * 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension

Also Published As

Publication number Publication date
AR123109A1 (es) 2022-10-26
IL300129A (en) 2023-03-01
EP4188324A1 (en) 2023-06-07
CA3189404A1 (en) 2022-02-03
MX2023001004A (es) 2023-03-01
AU2021317182A1 (en) 2023-03-30
US20220031610A1 (en) 2022-02-03
WO2022024066A1 (en) 2022-02-03
TW202220638A (zh) 2022-06-01
CN115968281A (zh) 2023-04-14
JP2023535829A (ja) 2023-08-21

Similar Documents

Publication Publication Date Title
US10087107B2 (en) Geopolymer with nanoparticle retardant and method
BR0313160A (pt) Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto
BR112015023520A2 (pt) purificação do conjugado de anticorpo-fármaco (adc)
BRPI0717970B8 (pt) composto inibidor de 11betahsd1, composição farmacêutica, e, uso do composto
MA30762B1 (fr) Anticorps specifiques du prlr et leurs utilisations
BRPI0514922A (pt) processo para a produção de um material básico revestido para uma composição hidráulica, material básico revestido para uma composição hidráulica, aditivo para uma composição hidráulica e processo para a produção de uma composição hidráulica
MX2021009679A (es) Minimizacion de aglomeracion, aireacion y conservacion del revestimiento de composiciones farmaceuticas que comprenden ibuprofeno.
BR112022021690A2 (pt) Anticorpos de cadeia pesada multispecíficos com regiões constantes de cadeia pesada modificadas
BR112023027004A2 (pt) Estrutura de metal-orgânica, uso da estrutura de metal-orgânica, composição para uso na redução da nitrificação, mistura agroquímica e métodos de redução da nitrificação, de tratamento de fertilizante ou composição de fertilizante e de preparação de uma estrutura de metal-orgânica
CN109233474A (zh) 一种内墙装饰涂料及其制备工艺
BR112023001716A2 (pt) Composições farmacêuticas compreendendo api revestido
SG11201900700SA (en) Fly ash, cement composition, and production method for fly ash
ZA202202966B (en) Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
BR112021023323A2 (pt) Ésteres de glicerol etoxilados e método para a produção dos mesmos
MX2023009724A (es) Sustitucion de amoniaco en productos para alterar el cabello.
BR112023005226A2 (pt) Composição para promover o microbioma da pele
EA202192246A1 (ru) Состав с афабицином, способ его получения и его применение
BR112021023934A2 (pt) Dispersão aquosa, processos para preparar uma dispersão aquosa e para revestir um substrato, uso de uma dispersão aquosa, e, grânulo ou semente de fertilizante revestido
BR112021020740A2 (pt) Material plano e método para a produção do mesmo
CN106380092B (zh) 一种利用脱硫石灰作为缓凝剂的水泥
BR112021019300A2 (pt) Composto, composição farmacêutica, e método para tratar câncer em um indivíduo que necessita do mesmo
AR121271A1 (es) Composiciones auxiliares de flujo
BR112023024012A2 (pt) Uso de composto de etinilpiridina, composição para uso na redução da nitrificação, mistura agroquímica e métodos de redução da nitrificação e de tratamento de fertilizante ou composição
BR112022019004A2 (pt) Composição à base de sulfato de ureia amônio
BRPI0506550A (pt) uso do metronidazol para a preparação de uma composição farmacêutica